Impact of epidermal growth factor on the treatment of diabetic foot ulcers
Human Epidermal Growth Factor (hEGF), obtained through recombinant DNA technology and formulated as Heberprot-P at a dosage of 75 µg, can stimulate the granulation and cicatrization of different tissues. This work is aimed mainly at the evaluation of the impact of the intralesional administration of...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elfos Scientiae
|
| Series: | Biotecnología Aplicada |
| Subjects: | |
| Online Access: | http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200008&lng=en&tlng=en |